News

Wall Street is muted on Friday, with the major averages looking for clear direction as investors digest the previous ...
The average Wall Street analyst following Editas Medicine (NASDAQ: EDIT) thinks the gene therapy stock can reach $3.25 per share in the next year. From recent prices, this implies a gain of ...
U.S. stock futures moved in different directions on Thursday, with enthusiasm for a potential U.S.-EU trade agreement ...
The stock market opened higher on Friday, a day after the S&P 500 and Nasdaq Composite hit fresh record high closes. The S&P 500 (SP500) +0.1%, the Dow (DJI) +0.2%, and the Nasdaq Composite (COMP:IND) ...
And Wall Street’s “fear gauge,” the VIX, exploded to rare heights… On April 8, the VIX closed above 50. We’ve only seen this level or higher in 2008, 2009, and 2020.
Nasdaq beat Wall Street estimates for second-quarter profit on Thursday, as volatile markets boosted trading volumes while ...
S&P 500 is heavily dominated by mega-cap tech stocks. Currently, the "Magnificent Seven" — Apple, Microsoft, Amazon, Alphabet ...
The average of price targets set by Wall Street analysts indicates a potential upside of 25.5% in Arcosa (ACA). While the effectiveness of this highly sought-after metric is questionable, the ...